Addictions, Drug & Alcohol Institute

Tanja Laschober PhD

Dr. Laschober is a Research Scientist at the Addictions, Drug & Alcohol Institute. She is currently the Local Project Director of CTN Protocol 0110 Randomized, Double-Blind, Placebo-Controlled Trial of Monthly Injectable Buprenorphine for Methamphetamine Use Disorder (MURB) and National Project Director of CTN Protocol 0082 Implementation Survey of PrEP and Opioid Use Related Services in STI Clinics and MSM-Centered Community Based Organizations (CBOs) for the Pacific Northwest Node of The National Drug Abuse Treatment Clinical Trials Network (CTN). She is also the Project Manager for a UW/Fred Hutch CFAR grant-funded project that focuses on the expansion of harm reduction services at a syringe service program in Memphis, TN.

Dr. Laschober’s experience includes project management, data management, quantitative analysis, writing, and dissemination of findings. She is also a consultant with the Clinical Trials Consultation and Technical Assistance Program (C-TAP) within the UW Department of Psychiatry and Behavioral Sciences. She further provides statistical, grant-writing, and manuscript-writing support to members of the Pacific Northwest Node. She also serves as a reviewer for the CTN Publications Committee.

Dr. Laschober’s previous research has focused on the adoption, implementation, and sustainability of evidence-based practices, evaluation of mandatory smoking cessation policies, and workforce development in substance use disorder treatment programs. She also has experience with interventions to safely disclose HIV-positive status among men who have sex with men.


Research Scientist


PhD, Human Development and Family Studies, University of Missouri - Columbia
MS, Human Development and Family Studies, University of Missouri – Columbia
BS, Human Development and Family Studies, Pennsylvania State University – Altoona

Linked Information

uw_icons_anchor Research

Research Interests

  • Treatment and prevention of substance use disorders
  • Adoption, implementation, and sustainability of evidence-based practices
  • HIV prevention and treatment
  • Program evaluation; effectiveness of interventions
  • Workforce development (e.g., employee performance, turnover, work-life balance, mentor-mentee relationships)
  • Human development across the life course (e.g., sociological, psychological, mental, and behavioral well-being)

Research & Other Projects